Consider a scenario where a new drug acts as a non-competitive inhibitor for a key metabolic enzyme. What could be the potential outcomes for the organism's health?

• A. The organism may experience reduced metabolic efficiency, potentially leading to energy deficits.
• B. The organism's enzymes will become permanently inactive.
• C. The organism's metabolic rate will increase, leading to faster growth.
• D. The organism will become immune to all diseases.

Answer: (A)